English | Deutsch

m law group advises QureInvest in series A financing round of Medoderm GmbH

01.04.2010

m law group advises QureInvest in a series A financing round of Medoderm GmbH.

The proceeds of the financing round will be used to advance Medoderm's research and technology programs in order to eventually enter into a strategic alliance with a major medtech company active in the field of woundhealing.

QureInvest is a fund investing equity in biotech and life science businesses with a focus on seed and early stage companies.

Medoderm is active in the application and commercial exploitation of the company’s technology for highly innovative biomaterials, including but not limited to Chitosan, in the field of wound healing and externally applied products in medical and cosmetic dermatology. The company's corporate headquarters and research facility are located in Mainz, Germany.

Counsel to QureInvest:
m law group, Munich: Dr. Hubert Besner, Dr. Florian Anselm, Dr. Stephan Appt, LL.M.

Counsel to Medoderm GmbH:
Pöllath + Partners, Munich: Christian Tönies LL.M.

Baker & McKenzie, Munich: Dr. Constanze Ulmer-Eilfort


Author: Dr. Hubert Besner
Practice Area: Start-up & Venture Capital
Industry: Life Science & Biotech